Live Breaking News & Updates on Assay development services

Stay informed with the latest breaking news from Assay development services on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Assay development services and stay connected to the pulse of your community

IVD Contract Research Organization Market ($8Bn by 2028)

The IVD Contract Research Organization Market Growth driven by the increasing demand for in-vitro diagnostics and clinical trials and new product launches...

New-york , United-states , Australia , Japan , United-kingdom , Argentina , Madrid , Spain , Brazil , China , Canada , Russia

The Worldwide Point of Care/Rapid Diagnostics Industry is Projected to Reach $50.6 Billion by 2025 at a CAGR of 11.4% from 2020

The Worldwide Point of Care/Rapid Diagnostics Industry is Projected to Reach $50.6 Billion by 2025 at a CAGR of 11.4% from 2020
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

China , United-states , India , Dublin , Ireland , America , Siemens-healthineers , Asia-pacific , Laura-wood , Dynamic-companies , Quidel-corporation , Trinity-biotech

The Worldwide Point of Care/Rapid Diagnostics Industry is Projected to Reach $50.6 Billion by 2025 at a CAGR of 11.4% from 2020

The Worldwide Point of Care/Rapid Diagnostics Industry is Projected to Reach $50.6 Billion by 2025 at a CAGR of 11.4% from 2020
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

China , United-states , India , Dublin , Ireland , America , Siemens-healthineers , Asia-pacific , Laura-wood , Dynamic-companies , Quidel-corporation , Trinity-biotech

AnteoTech's AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test     Labmate Online


Derek Thomson, Chief Executive Officer at AnteoTech.
AnteoTech’s AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test    
Feb 23 2021 Read 941 Times
AnteoTech's long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test. The test uses AnteoTech’s unique AnteoBind™ technology to support significantly improved sensitivity, and is the first rapid self-test for SARS-CoV-2 detection authorised by the United States Food and Drug Administration (FDA) for use without a prescription. Through the patented AnteoBind technology and the expertise and know-how delivered via its Contract Services in assay development and bioconjugation, AnteoTech continues to address the pressing challenges of the point-of-care diagnostics, biopharmaceutical and vaccine development markets.

United-states , Anteotech-anteobind , Derek-thomson , Sean-parsons , Assay-development-services , Drug-administration , Contract-services , Anteotech-assay-development-services , United-states-food , Use-authorisation , Chief-executive-officer , Emergency-use-authorization

AnteoTech's AnteoBind™ Technology Supports First-of-its-Kind COVID-19 Home Test     Labmate Online

AnteoTech's AnteoBind™ Technology Supports First-of-its-Kind COVID-19 Home Test     Labmate Online
labmate-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labmate-online.com Daily Mail and Mail on Sunday newspapers.

United-states , Anteotech-anteobind , Derek-thomson , Sean-parsons , Assay-development-services , Drug-administration , Contract-services , Anteotech-assay-development-services , United-states-food , Use-authorisation , Chief-executive-officer , Emergency-use-authorization

Global Cardiac Marker Testing Market (2020 to 2025) - Emerging Markets to Offer High-Growth Opportunities for Players


Share this article
Share this article
ResearchAndMarkets.com's offering.
The global cardiac marker testing market is projected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2020, at a CAGR of 8.9%.
The growth in the cardiac marker testing market is majorly driven by the growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent.

Mexico , Japan , United-states , India , Brazil , China , Canada , Russia , Dublin , Ireland , South-korea , America